COSEHC global vascular risk management quality improvement program: rationale and design

References

• DaskalopoulouSSAthyrosVGKolovouGDAnagnostopoulouKKMikhailidisDPDefinitions of metabolic syndrome: Where are we now?Curr Vasc Pharmacol20064318519716842136
   PubMedGoogle Scholar
• National Cholesterol Education Program Adult Treatment Panel IIIThird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• AndreassiMGMetabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interactionMutat Res20096671–2354319028510
   PubMed Web of Science ®Google Scholar
• KrajaATProvinceMAArnettDDo inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?Nutr Metab (Lond)200742818154661
   PubMed Web of Science ®Google Scholar
• PotenzaMVMechanickJIThe metabolic syndrome: Definition, global impact, and pathophysiologyNutr Clin Pract200924556057719841245
   PubMed Web of Science ®Google Scholar
• GamiASWittBJHowardDEMetabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studiesJ Am Coll Cardiol200749440341417258085
   PubMed Web of Science ®Google Scholar
• de SimoneGDevereuxRBChinaliMPrognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: The Strong Heart StudyDiabetes Care20073071851185617440172
   PubMed Web of Science ®Google Scholar
• DekkerJMGirmanCRhodesTMetabolic syndrome and 10-year cardiovascular disease risk in the Hoorn StudyCirculation2005112566667316061755
   PubMed Web of Science ®Google Scholar
• HoJSCannadayJJBarlowCEMitchellTLCooperKHFitzGeraldSJRelation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortalityAm J Cardiol2008102668969218773989
   PubMed Web of Science ®Google Scholar
• GirmanCJDekkerJMRhodesTAn exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: The Hoorn studyAm J Epidemiol2005162543844716076828
   PubMed Web of Science ®Google Scholar
• RedbergRFBenjaminEJBittnerVACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health ResearchCirculation2009120131296133619770388
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBSrGrundySSullivanLMWilsonPValidation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigationJAMA2001286218018711448281
   PubMed Web of Science ®Google Scholar
• HemannBABimsonWFTaylorAJThe Framingham Risk Score: An appraisal of its benefits and limitationsAm Heart Hosp J200752919617478974
   PubMedGoogle Scholar
• ManciaGde BackerGDominiczakA2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J200728121462153617562668
   PubMed Web of Science ®Google Scholar
• SehestedtTJeppesenJHansenTWRisk prediction is improved by adding markers of subclinical organ damage to SCOREEur Heart J201031788389120034972
   PubMed Web of Science ®Google Scholar
• SchlendorfKHNasirKBlumenthalRSLimitations of the Framingham risk score are now much clearerPrev Med200948211511619124038
   PubMed Web of Science ®Google Scholar
• LiuJHongYD’AgostinoRBSrPredictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort StudyJAMA2004291212591259915173150
   PubMed Web of Science ®Google Scholar
• van der HeijdenAAOrtegonMMNiessenLWNijpelsGDekkerJMPrediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: Accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn StudyDiabetes Care200932112094209819875606
   PubMed Web of Science ®Google Scholar
• EmpanaJPDucimetièrePArveilerDAre the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME StudyEur Heart J2003242119031191114585248
   PubMed Web of Science ®Google Scholar
• AssmannGCullenPSchulteHSimple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) studyCirculation2002105331031511804985
   PubMed Web of Science ®Google Scholar
• ConroyRMPyöräläKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE projectEur Heart J20032411987100312788299
   PubMed Web of Science ®Google Scholar
• HallWDFerrarioCMMooreMAHypertension-related morbidity and mortality in the southeastern United StatesAm J Med Sci199731341952099099149
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDAdamsRJBrownTMHeart disease and stroke statistics – 2010 Update A report from the American Heart AssociationCirculation20101217e46e21520019324
   PubMed Web of Science ®Google Scholar
• PocockSJMcCormackVGueyffierFBoutitieFFagardRHBoisselJPA score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trialsBMJ20013237304758111451781
   PubMedGoogle Scholar
• HoustonMCBasileJBestermannWHAddressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United StatesAm J Med Sci2005329627629115958870
   PubMed Web of Science ®Google Scholar
• BestermannWHoustonMCBasileJAddressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: Treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndromeAm J Med Sci2005329629230515958871
   PubMed Web of Science ®Google Scholar
• SAS Institute, IncThe MI procedureSAS OnlineDoc^® 9.1.3Cary, NCSAS Institute2008
   Google Scholar
• KassRECarlinBPGelmanANealRMMarkov chain Monte Carlo in practice: A roundtable discussionAm Stat19985293100
   Web of Science ®Google Scholar
• CollinsGSAltmanDGAn independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort studyBMJ2009339b258419584409
   PubMed Web of Science ®Google Scholar
• BrindlePEmbersonJLampeFPredictive accuracy of the Framingham coronary risk score in British men: Prospective cohort studyBMJ20033277426126714644971
   PubMed Web of Science ®Google Scholar
• CooperJAMillerGJHumphriesSEA comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart StudyAtherosclerosis200518119310015939059
   PubMed Web of Science ®Google Scholar
• NeuhauserHKEllertUKurthBMA comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998Eur J Cardiovasc Prev Rehabil200512544245016210930
   PubMedGoogle Scholar
• UlmerHKolleritsBKelleherCDiemGConcinHPredictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: A prospective evaluation of 44,649 Austrian men and womenEur J Cardiovasc Prev Rehabil200512543344116210929
   PubMedGoogle Scholar